{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.14.10-dev",
    "document_metadata": {
      "name": "Calcium-2.0-Hs",
      "authors": "Causal Biological Networks Database",
      "licenses": "\t        Please cite:\t\t        - www.causalbionet.com\t        - https://bionet.sbvimprover.com\t\t        as well as any relevant publications.\t\t        The sbv IMPROVER project, the website and the Symposia are part of a collaborative project\t        designed to enable scientists to learn about and contribute to the development of a new crowd\t        sourcing method for verification of scientific data and results. The current challenges, website\t        and biological network models were developed and are maintained as part of a collaboration among\t        Selventa, OrangeBus and ADS. The project is led and funded by Philip Morris International. For more\t        information on the focus of Philip Morris Internationalâ€™s research, please visit www.pmi.com.\t        ",
      "version": "2.0",
      "contact": "CausalBiologicalNetworks.RD@pmi.com",
      "description": "The Calcium network depicts the causal mechanisms that regulate calcium signaling in the context of cell proliferation. The network describes increases in calcineurin complex activity as a result of Wnt-mediated calcium signaling and VEGF signaling, which leads to the induction of NFATC1 transcriptional activity and subsequent cell proliferation. \\nReviewed during Jamboree2015"
    },
    "namespace_url": {},
    "namespace_pattern": {
      "go": ".*",
      "chebi": ".*",
      "fplx": ".*",
      "hgnc": ".*"
    },
    "annotation_url": {},
    "annotation_pattern": {
      "cl": ".*"
    },
    "annotation_list": {}
  },
  "nodes": [
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "calcitriol",
        "identifier": "17823"
      },
      "id": "fd4025d982d7a2c61a3d50ffc0b744a6",
      "bel": "a(chebi:17823 ! calcitriol)"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "store-operated calcium entry",
        "identifier": "0002115"
      },
      "id": "1354c9ea472c44f74cd19b47f69d1cf1",
      "bel": "bp(go:0002115 ! \"store-operated calcium entry\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "calcium ion import",
        "identifier": "0070509"
      },
      "id": "bac7721a37651b13afba7c8eaee01cd9",
      "bel": "bp(go:0070509 ! \"calcium ion import\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "NADPH_oxidase",
        "identifier": "NADPH_oxidase"
      },
      "id": "e9e1721e0b1c9510e72f534f365ffdd1",
      "bel": "complex(fplx:\"NADPH_oxidase\" ! \"NADPH_oxidase\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "PPP3",
        "identifier": "PPP3"
      },
      "id": "c68eaef675a7f9e15be7f041a9b7c5c4",
      "bel": "complex(fplx:PPP3 ! PPP3)"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFA",
            "identifier": "8799"
          },
          "id": "aa494a1240c61645cad1581cbc7788b2",
          "bel": "p(hgnc:8799 ! PDGFA)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "PDGFA",
            "identifier": "8799"
          },
          "id": "aa494a1240c61645cad1581cbc7788b2",
          "bel": "p(hgnc:8799 ! PDGFA)"
        }
      ],
      "id": "895a74a78ee41a24c42234d81b2709bd",
      "bel": "complex(p(hgnc:8799 ! PDGFA), p(hgnc:8799 ! PDGFA))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "CAMK2_family",
        "identifier": "CAMK2_family"
      },
      "id": "e9622e99e68cca8d866086806f65f66c",
      "bel": "p(fplx:\"CAMK2_family\" ! \"CAMK2_family\")"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "STIM1",
        "identifier": "11386"
      },
      "id": "ff33c05deb69e1ab4832187693dee0d0",
      "bel": "p(hgnc:11386 ! STIM1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VEGFA",
        "identifier": "12680"
      },
      "id": "710d068636280068962cf864d9ed7526",
      "bel": "p(hgnc:12680 ! VEGFA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "WNT5A",
        "identifier": "12784"
      },
      "id": "602e83c5a7bccbbb27b023482dcc4d19",
      "bel": "p(hgnc:12784 ! WNT5A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCND1",
        "identifier": "1582"
      },
      "id": "7948aef17947d3efb076ccc443c7c3a6",
      "bel": "p(hgnc:1582 ! CCND1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CDK4",
        "identifier": "1773"
      },
      "id": "10af669e3e8e2a8855be9401ca30a72f",
      "bel": "p(hgnc:1773 ! CDK4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CHRNA7",
        "identifier": "1960"
      },
      "id": "958be0689fe8ad9a3c40aef25c3612f5",
      "bel": "p(hgnc:1960 ! CHRNA7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ORAI1",
        "identifier": "25896"
      },
      "id": "1d540254e035dee1ec0236fd3e79d65c",
      "bel": "p(hgnc:25896 ! ORAI1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RCAN1",
        "identifier": "3040"
      },
      "id": "e108f4d0d22c1478c82e65e5d271baad",
      "bel": "p(hgnc:3040 ! RCAN1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGF2",
        "identifier": "3676"
      },
      "id": "15956b3e3182f3f4e8bc88068182b9c7",
      "bel": "p(hgnc:3676 ! FGF2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FGFR1",
        "identifier": "3688"
      },
      "id": "473b5d31306a390fe0360a2d152df990",
      "bel": "p(hgnc:3688 ! FGFR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ATP8B1",
        "identifier": "3706"
      },
      "id": "b198c49b0b12bc424df8b65560f48310",
      "bel": "p(hgnc:3706 ! ATP8B1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MTOR",
        "identifier": "3942"
      },
      "id": "42eb159bca5cd4a7a0c4c5499d3772d3",
      "bel": "p(hgnc:3942 ! MTOR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FZD2",
        "identifier": "4040"
      },
      "id": "229361c67efb9db32c5e06c55ee3eaca",
      "bel": "p(hgnc:4040 ! FZD2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ITPR1",
        "identifier": "6180"
      },
      "id": "3446c46222ab90b41a915a896a7be11c",
      "bel": "p(hgnc:6180 ! ITPR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ITPR2",
        "identifier": "6181"
      },
      "id": "dfd59ab84560697c039fd2a638d6785b",
      "bel": "p(hgnc:6181 ! ITPR2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ITPR3",
        "identifier": "6182"
      },
      "id": "4e0b72773feb67c5be56780decf2864d",
      "bel": "p(hgnc:6182 ! ITPR3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "KDR",
        "identifier": "6307"
      },
      "id": "04acdd6fe94a9adc2b80c0d3a611cc56",
      "bel": "p(hgnc:6307 ! KDR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK7",
        "identifier": "6880"
      },
      "id": "e4df96eaac7aa4a28d505222ba6a68b0",
      "bel": "p(hgnc:6880 ! MAPK7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFATC1",
        "identifier": "7775"
      },
      "id": "63d031a12c39ea047fd35fd113ac7aac",
      "bel": "p(hgnc:7775 ! NFATC1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PDGFA",
        "identifier": "8799"
      },
      "id": "aa494a1240c61645cad1581cbc7788b2",
      "bel": "p(hgnc:8799 ! PDGFA)"
    }
  ],
  "links": [
    {
      "line": 1,
      "relation": "increases",
      "evidence": "Regions of fibroblast hypercellularity induced by EB1089 were strongly positive for expression of the alveolarization-relevant growth factors, PDGF-AA and vascular endothelial growth factor (VEGF).",
      "citation": {
        "db": "PubMed",
        "db_id": "18432454"
      },
      "annotations": {
        "cl": {
          "0000057": true
        }
      },
      "source": 0,
      "target": 8,
      "key": "134f0f8acd02f63be12d6889d5f87d7e"
    },
    {
      "line": 2,
      "relation": "increases",
      "evidence": "Regions of fibroblast hypercellularity induced by EB1089 were strongly positive for expression of the alveolarization-relevant growth factors, PDGF-AA and vascular endothelial growth factor (VEGF).",
      "citation": {
        "db": "PubMed",
        "db_id": "18432454"
      },
      "annotations": {
        "cl": {
          "0000057": true
        }
      },
      "source": 0,
      "target": 5,
      "key": "2dc86e5b1515526580416e078fa0dd6b"
    },
    {
      "line": 17,
      "relation": "increases",
      "evidence": "Herein we demonstrate that activation of NFATc1 in human pulmonary valve endothelial cells is specific to vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2. VEGF-induced (VEGF165) NFATc1 nuclear translocation was inhibited by either cyclosporin A or a calcineurin-specific peptide inhibitor;",
      "citation": {
        "db": "PubMed",
        "db_id": "12427739"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 4,
      "target": 25,
      "key": "004411b28038b704dbab5c7d1c0c1fc1"
    },
    {
      "line": 17,
      "relation": "increases",
      "evidence": "Cotransfection of Jurkat cells with vGPCR and an NF-AT luciferase reporter plasmid showed that vGPCR activated NF-AT in a dose-dependent fashion, as judged by NF-AT luciferase reporter gene expression. The activation was calcineurin dependent because it was suppressed by cyclosporine A (CSA), a highly specific calcineurin inhibitor. Cotransfected expression constructs for NF-AT1 and NF-AT2 with vGPCR into KS cells showed that only NF-AT1 and NF-AT2 were activated by vGPCR.",
      "citation": {
        "db": "PubMed",
        "db_id": "12719569"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 4,
      "target": 25,
      "key": "34f0d9ff7abdbac090f53eb7ed38cc76"
    },
    {
      "line": 17,
      "relation": "increases",
      "evidence": "IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Thus, IGF-1 induces calcineurin-mediated signalling and activation of GATA-2, a marker of skeletal muscle hypertrophy, which cooperates with selected NF-ATc isoforms to activate gene expression programs.",
      "citation": {
        "db": "PubMed",
        "db_id": "10448862"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 4,
      "target": 25,
      "key": "4a2e2cb0c6ef76c755f40f5b3595d955"
    },
    {
      "line": 17,
      "relation": "increases",
      "evidence": "CnA* muscles displayed threefold higher calcineurin activity and enhanced dephosphorylation of the calcineurin targets NFATc1, MEF2A, and MEF2D.",
      "citation": {
        "db": "PubMed",
        "db_id": "11062266"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 4,
      "target": 25,
      "key": "572907a890c897875bd5f53e7c3249f4"
    },
    {
      "line": 15,
      "relation": "decreases",
      "evidence": "DPI, added to the cells at the time of maximum FMLP-activated membrane depolarisation, accelerated the rates of both membrane repolarisation and influx of Ca(2+)",
      "citation": {
        "db": "PubMed",
        "db_id": "15163557"
      },
      "annotations": {
        "cl": {
          "0000775": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 3,
      "target": 2,
      "key": "0ac6f9fb1755d911a688c4f005f6d650"
    },
    {
      "relation": "partOf",
      "source": 26,
      "target": 5,
      "key": "0179cf54b34bd093cc27ba24eaa46782"
    },
    {
      "line": 18,
      "relation": "directlyIncreases",
      "evidence": "Calcitriol (1,25 (OH)2D3), a major regulator of mineral metabolism, is generated by 25-hydroxyvitamin D 1Î±-hydroxylase in the kidney. Since 25-hydroxyvitamin D 1Î±-hydroxylase expression is enhanced by IRF-1, the present study explored the role of Chk2 for calcitriol formation and mineral metabolism",
      "citation": {
        "db": "PubMed",
        "db_id": "25319519"
      },
      "annotations": {},
      "source": 17,
      "target": 0,
      "key": "d03a91147e4536535ff959e43b42eb43"
    },
    {
      "line": 34,
      "relation": "increases",
      "evidence": "Nicotine-induced Ca(2+) response was reversibly blocked by the Î±7-nAChR nicotinic antagonists, methyllycaconitine and Î±-bungarotoxin. Small interfering RNA suppression of Î±7-nAChR also substantially blunted the Ca(2+) responses induced by nicotine.",
      "citation": {
        "db": "PubMed",
        "db_id": "24525957"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 12,
      "target": 2,
      "key": "374000d099761646d09eac9bc8e1b0df"
    },
    {
      "line": 10,
      "relation": "directlyIncreases",
      "evidence": "GF-2 (>/=10(-12) m) up-regulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts.",
      "citation": {
        "db": "PubMed",
        "db_id": "10896947"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 15,
      "target": 16,
      "key": "40cd2f3082e2d70705cf144f24742842"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "In cells treated with RNAi specifically designed against frizzled-2, intracellular Ca(2+) in both hypoxia/reoxygenation-treated cells and plasmid-treated cells were decreased.",
      "citation": {
        "db": "PubMed",
        "db_id": "22510436"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 19,
      "target": 2,
      "key": "d2b2ad0c0b18c611bc154280c2a419fb"
    },
    {
      "line": 41,
      "relation": "increases",
      "evidence": "Pretreating cells with (-)-xestospongin C (10 microM) or ryanodine (400 microM), the antagonists of inositol 1,4,5-trisphosphate receptor (IP3R) or ryanodine receptor (RyR), respectively, facilitated store refilling and significantly reduced [Ca(2+)](i) elevation evoked by the passive store depletion or TCR ligation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18316371"
      },
      "annotations": {
        "cl": {
          "0000084": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "transporter activity",
          "identifier": "0005215"
        }
      },
      "source": 20,
      "target": 1,
      "key": "c8f1379042238ec16877458f9fbccb50"
    },
    {
      "line": 42,
      "relation": "increases",
      "evidence": "Pretreating cells with (-)-xestospongin C (10 microM) or ryanodine (400 microM), the antagonists of inositol 1,4,5-trisphosphate receptor (IP3R) or ryanodine receptor (RyR), respectively, facilitated store refilling and significantly reduced [Ca(2+)](i) elevation evoked by the passive store depletion or TCR ligation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18316371"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "transporter activity",
          "identifier": "0005215"
        }
      },
      "source": 21,
      "target": 1,
      "key": "75abae17643aad5a5f758c609e97a680"
    },
    {
      "line": 37,
      "relation": "increases",
      "evidence": "Pretreating cells with (-)-xestospongin C (10 microM) or ryanodine (400 microM), the antagonists of inositol 1,4,5-trisphosphate receptor (IP3R) or ryanodine receptor (RyR), respectively, facilitated store refilling and significantly reduced [Ca(2+)](i) elevation evoked by the passive store depletion or TCR ligation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18316371"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "transporter activity",
          "identifier": "0005215"
        }
      },
      "source": 22,
      "target": 1,
      "key": "1396d9a4cb54349c8f5fc88d272b456f"
    },
    {
      "line": 26,
      "relation": "increases",
      "evidence": "Herein we demonstrate that activation of NFATc1 in human pulmonary valve endothelial cells is specific to vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2. VEGF-induced (VEGF165) NFATc1 nuclear translocation was inhibited by either cyclosporin A or a calcineurin-specific peptide inhibitor;",
      "citation": {
        "db": "PubMed",
        "db_id": "12427739"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 23,
      "target": 4,
      "key": "ea244e1335721afd1715b67933976246"
    },
    {
      "line": 26,
      "relation": "increases",
      "evidence": "VEGF-stimulated induction of DSCR1 was blocked by anti-VEGF receptor-2 monoclonal antibody (mAb), or the specific calcineurin inhibitors cyclosporin A and FK506.",
      "citation": {
        "db": "PubMed",
        "db_id": "15263820"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 23,
      "target": 4,
      "key": "bf0e8e58aa5b19e8bee1d97b7d25e281"
    },
    {
      "line": 47,
      "relation": "increases",
      "evidence": "Inhibition of Akt/mTOR blocks PDGF-induced stromal interacting molecule 1 (STIM1)/Orai1 expression and PASMC proliferation",
      "citation": {
        "db": "PubMed",
        "db_id": "22031597"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 18,
      "target": 7,
      "key": "dc70b437d57c1431b6d77d421533bfd1"
    },
    {
      "line": 19,
      "relation": "increases",
      "evidence": "Platelet-derived growth factor BB induced cyclin D1 expression in a time- and nuclear factor of activated T cells (NFAT)-dependent manner in human aortic smooth muscle cells (HASMCs), and blockade of NFATs prevented HASMC DNA synthesis and their cell cycle progression from G(1) to S phase....Balloon injury-induced cyclin D1-CDK4 activity requires NFAT activation, and adenovirus-mediated transduction of cyclin D1 was found to be sufficient to overcome the blockade effect of NFATs",
      "citation": {
        "db": "PubMed",
        "db_id": "19933579"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 25,
      "target": 11,
      "key": "9c430020ad3026e146aa9ff1a515be47"
    },
    {
      "line": 20,
      "relation": "increases",
      "evidence": "Platelet-derived growth factor BB induced cyclin D1 expression in a time- and nuclear factor of activated T cells (NFAT)-dependent manner in human aortic smooth muscle cells (HASMCs), and blockade of NFATs prevented HASMC DNA synthesis and their cell cycle progression from G(1) to S phase....Balloon injury-induced cyclin D1-CDK4 activity requires NFAT activation, and adenovirus-mediated transduction of cyclin D1 was found to be sufficient to overcome the blockade effect of NFATs",
      "citation": {
        "db": "PubMed",
        "db_id": "19933579"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 25,
      "target": 10,
      "key": "4c210410e4a8f564bda0b113c9d6de6f"
    },
    {
      "line": 45,
      "relation": "increases",
      "evidence": "We found that SOCE was upregulated during ASMC proliferation accompanied by a mild increase of STIM1 and a significant increase of Orai1 mRNA expression, whereas the proliferation of ASMCs was partially inhibited by the SOC channel blockers SKF-96365, NiCl(2), and BTP-2. Suppressing the mRNA expression of STIM1 or Orai1 with specific short hairpin RNA resulted in the attenuation of SOCE and ASMC proliferation. Moreover, after knockdown of STIM1 or Orai1, the SOC channel blocker SKF-96365 had no inhibitory effect on the proliferation of ASMCs anymore.",
      "citation": {
        "db": "PubMed",
        "db_id": "21330611"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "transporter activity",
          "identifier": "0005215"
        }
      },
      "source": 13,
      "target": 1,
      "key": "8ab6b2671045be0e9fbd4fe00f4e69b1"
    },
    {
      "line": 43,
      "relation": "increases",
      "evidence": "FIGURE 5 | The CRAC-channelâ€“calciumâ€“calcineurinâ€“NFAT signalling pathway as a target for therapeutic immune modulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17703229"
      },
      "annotations": {
        "cl": {
          "0000084": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "transporter activity",
          "identifier": "0005215"
        }
      },
      "source": 7,
      "target": 13,
      "key": "30eb62a4dbe2f18d059f6f4f1220d083"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "once bound to its receptor, VEGF initiates an intracellular signaling cascade that leads to changes in expression of the gene that promote endothelial cell migration and proliferation",
      "citation": {
        "db": "PubMed",
        "db_id": "12793895"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 8,
      "target": 23,
      "key": "c5638854d9de4a55b844452896f12607"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "The beta3 integrin is necessary for the activation of PI 3-kinase in endothelial cells stimulated by VEGF-A165  PI 3-kinase belongs to the intracellular signals triggered by VEGF-A in bovine endothelial cells, as demonstrated by the phosphorylation of its regulatory protein p85 (Guo et al., 1995). As shown in Figure 5, wortmannin used at nanomolar concentrations specific for PI 3-kinase inhibition (Arcaro and Wymann, 1993), reduced the human endothelial cells migration induced by VEGF-A165. To determine whether beta3 integrin interferes in PI 3-kinase activation occurring after VEGFR-2 stimulation, we evaluated the effect of BV4 (anti-beta3 subunit mAb) on the phosphorylation in tyrosine residues of the p85 subunit and on the catalytic activity of the enzyme. After pre-incubation with BV4 or with anti-VEGFR-2 Ab for 20 min at 4Â°C, cells were stimulated with VEGF-A165. Cell lysates were immunoprecipitated with anti-p85 mAb, and the separated proteins by SDSâ€“PAGE were probed with anti-phosphotyrosine mAb. VEGF-A165 increased the tyrosine phosphorylation of p85, but it failed to phosphorylate the PI 3-kinase subunit when endothelial cells were pre-incubated with anti-beta3 or anti-VEGFR-2 antibodies (Figure 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "10022831"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 8,
      "target": 23,
      "key": "41ed6e167dc21a63389f78ddde7b9a3b"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "Herein we demonstrate that activation of NFATc1 in human pulmonary valve endothelial cells is specific to vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2. VEGF-induced (VEGF165) NFATc1 nuclear translocation was inhibited by either cyclosporin A or a calcineurin-specific peptide inhibitor;",
      "citation": {
        "db": "PubMed",
        "db_id": "12427739"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 8,
      "target": 23,
      "key": "bc8935cebeee01b8303611d918874f35"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "Pharmacological intervention with a VEGFR-2-neutralizing Ab (anti-Flk1 mAb) abolished the production of IL-6 (but not IL-12p70) and the subsequent development of allergen-specific Th17 cell response.",
      "citation": {
        "db": "PubMed",
        "db_id": "20921519"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 8,
      "target": 23,
      "key": "29b6c163718b8a4eb5346c5be23a59c1"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "from full text - All VEGF-A isoforms bind to both VEGFR-1 and VEGFR-2, whereas PlGF and VEGF-B are selective ligands for VEGR-1.  VEGF-C and VEGF-D interact with both VEGFR-3 and VEGFR-2, whereas VEGF-E is a selective ligand for VEGFR-2 (VEGFR1=FLT1, VEGFR2=KDR, VEGFR3=FLT4, VEGFD=FIGF, VEGFE is virus-dervied, so not scripted)",
      "citation": {
        "db": "PubMed",
        "db_id": "16835467"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 8,
      "target": 23,
      "key": "bda3e3c69346a596156afc045521fda2"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "VEGF-A, the prototype VEGF ligand, binds and activates two tyrosine kinase receptors: VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1).",
      "citation": {
        "db": "PubMed",
        "db_id": "16336962"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 8,
      "target": 23,
      "key": "2d9e98db00c866fa6f7441e9bdc0f635"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "as well as VEGFA, other VEGF-family members are produced by human tumors, including VEGFC and VEGFD, which both bind to VEGFR2 and activate many of the same pathways as VEGFA",
      "citation": {
        "db": "PubMed",
        "db_id": "12778130"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 8,
      "target": 23,
      "key": "d5d9d3a114b91e4ac49f99d4cc58982d"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "VEGF levels are also regulated by tissue oxygen tension. Exposure to hypoxia induces VEGF expression rapidly and reversibly, through both increased transcription and stabilization of the mRNA (108, 162).",
      "citation": {
        "db": "PubMed",
        "db_id": "11172729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 8,
      "target": 23,
      "key": "2e0d86fa879f8991bd72a094535d8f52"
    },
    {
      "line": 13,
      "relation": "directlyIncreases",
      "evidence": "VEGF actions are mediated through binding to 2 receptor tyrosine kinases, VEGFR1 (FLT1) and VEGFR2 (KDR)",
      "citation": {
        "db": "PubMed",
        "db_id": "15178810"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 8,
      "target": 23,
      "key": "aebc58ee40760dc7a41d0177c0661d3e"
    },
    {
      "line": 14,
      "relation": "directlyIncreases",
      "evidence": "Changes in Wnt5a and Fzd2 expression in the spinal cord of SOD1(G93A) transgenic mice (ALS), SOD1(G93A) transfected NSC-34 cells, and primary cultures of astrocytes from SOD1(G93A) transgenic mice were detected by immunofluorescent staining, reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting",
      "citation": {
        "db": "PubMed",
        "db_id": ""
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 9,
      "target": 19,
      "key": "5e11b6d9054c0f285b27902d5c662089"
    },
    {
      "line": 14,
      "relation": "directlyIncreases",
      "evidence": "Activation of Frizzled-2 by Wnt5a leads to activation of the phosphatidylinositol pathway (11), activation of the cyclic GMP phosphodiesterase PDE6 (13, 16), and inhibition of protein kinase G (PKG)2  (17), which leads to Ca2+ mobilization (17). [Ma, L., and Wang, H. Y. (2006) J. Biol. Chem. 281, 30990-31001]",
      "citation": {
        "db": "PubMed",
        "db_id": "17684012"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 9,
      "target": 19,
      "key": "8572d713b54bc2d7d94c3f220910e760"
    }
  ]
}